info@synchemia.com | sales@synchemia.com 
9766925136 
Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142467 |
| CAS No | NA |
| Mol.F. | C17H16N4O7S |
| Mol.Wt. | 420.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142468 |
| CAS No | NA |
| Mol.F. | C12H10ClN3O6S |
| Mol.Wt. | 359.7 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142469 |
| CAS No | NA |
| Mol.F. | C12H14ClN3O6S |
| Mol.Wt. | 363.8 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142470 |
| CAS No | NA |
| Mol.F. | C4H2N6O2 |
| Mol.Wt. | 166.10 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142471 |
| CAS No | NA |
| Mol.F. | C4H5N5O2 |
| Mol.Wt. | 155.12 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142472 |
| CAS No | NA |
| Mol.F. | C2H6N2O |
| Mol.Wt. | 74.08 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142473 |
| CAS No | NA |
| Mol.F. | C4H4N6O2 |
| Mol.Wt. | 168.12 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142474 |
| CAS No | NA |
| Mol.F. | C16H25N5O12 |
| Mol.Wt. | 479.40 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142475 |
| CAS No | NA |
| Mol.F. | C15H21N3O4 |
| Mol.Wt. | 307.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142476 |
| CAS No | NA |
| Mol.F. | C15H21N3O4 |
| Mol.Wt. | 307.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142477 |
| CAS No | NA |
| Mol.F. | C6H12N4O6S |
| Mol.Wt. | 268.24 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142478 |
| CAS No | NA |
| Mol.F. | C13H18N4O3 |
| Mol.Wt. | 278.31g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142479 |
| CAS No | NA |
| Mol.F. | C25H30ClN3O6 |
| Mol.Wt. | 503.98 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142480 |
| CAS No | NA |
| Mol.F. | C20H21N3O4 |
| Mol.Wt. | 367.41g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142481 |
| CAS No | NA |
| Mol.F. | C15H19N32O4 |
| Mol.Wt. | 305.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142482 |
| CAS No | NA |
| Mol.F. | C15H28N2O7S |
| Mol.Wt. | 380.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
